Ackermans & Van Haaren NV (GB:0GYM) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ackermans & van Haaren NV reports a strong third quarter in 2024, maintaining momentum with core participations like DEME and Delen Private Bank, and projects a net profit exceeding 400 million euros for the year. The company bolstered its portfolio with strategic investments in V.Group and Confo Therapeutics, while also increasing stakes in Nextensa and SIPEF. AvH’s financial position remains solid with a net cash position of 294.8 million euros as of September 2024.
For further insights into GB:0GYM stock, check out TipRanks’ Stock Analysis page.